Previous studies strongly suggested that PRKAR1A dysregulation caused endocrine neoplasia, which was speculated to rely on tissues; however, its role in epithelium-generated tumors was rarely reported, especially in lung adenocarcinoma. This evidence concerns the gene PRKAR1A and lung adenocarcinoma.